| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.6B | $2.5B | $11.1B | $10.7B | $9.4B | $8.0B | $1.9B | $1.5B |
| Cost of Revenue | — | — | — | — | — | — | $0.0B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.9B | $0.9B | $1.0B | $1.0B | $0.8B | $0.8B | $0.7B | $0.5B |
| Operating Income | $4.8B | $1.1B | $3.0B | $2.4B | $3.1B | $2.9B | $0.7B | $0.5B |
| Net Income | $2.6B | $2.3B | $1.4B | $1.7B | $2.6B | $1.7B | $0.6B | $0.2B |
| EPS (Basic) | $5.41 | $2.63 | $3.18 | $3.83 | $5.69 | $3.81 | $1.27 | $0.48 |
| EPS (Diluted) | $5.40 | $2.62 | $3.18 | $3.82 | $5.66 | $3.79 | $1.26 | $0.47 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $63.2B | $61.1B | $66.0B | $67.2B | $69.9B | $47.2B | $42.8B | $30.9B |
| Current Assets | $2.7B | $3.2B | $3.7B | $3.6B | $3.7B | $2.9B | $2.6B | $1.7B |
| Cash & Equivalents | $1.5B | $2.0B | $2.0B | $2.0B | $1.9B | $1.7B | $1.5B | $0.8B |
| Total Liabilities | $52.8B | $51.4B | $55.2B | $54.8B | $60.8B | $42.5B | $36.2B | $22.8B |
| Current Liabilities | $6.9B | $7.1B | $7.2B | $8.3B | $9.1B | $3.7B | $5.5B | $1.6B |
| Stockholders' Equity | $3.7B | $3.4B | $4.2B | $5.6B | $5.1B | $4.1B | $5.1B | $6.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.5B | $5.3B | $4.7B | $3.7B | $4.8B | $3.9B | $3.8B | — |
| Investing Cash Flow | $-1.9B | $0.4B | $-1.7B | $-2.4B | $-20.7B | $-4.8B | $-4.0B | — |
| Capital Expenditures | $1.7B | $1.6B | $1.8B | $1.9B | $1.4B | $1.0B | $1.0B | $0.7B |
| Financing Cash Flow | $-4.2B | $-5.5B | $-3.1B | $-1.4B | $16.4B | $1.2B | $0.5B | — |